Adverum Biotechnologies Inc (ADVM)
10.43
+0.43
(+4.30%)
USD |
NASDAQ |
May 03, 16:00
10.47
+0.04
(+0.38%)
After-Hours: 20:00
Adverum Biotechnologies 1 Year Total Returns (Daily): 35.45% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 35.45% |
May 02, 2024 | 33.33% |
May 01, 2024 | 20.85% |
April 30, 2024 | 24.00% |
April 29, 2024 | 21.57% |
April 26, 2024 | 14.63% |
April 25, 2024 | 14.22% |
April 24, 2024 | 12.97% |
April 23, 2024 | 18.28% |
April 22, 2024 | 21.94% |
April 19, 2024 | 23.26% |
April 18, 2024 | 22.54% |
April 17, 2024 | 28.98% |
April 16, 2024 | 38.21% |
April 15, 2024 | 37.26% |
April 12, 2024 | 56.40% |
April 11, 2024 | 59.60% |
April 10, 2024 | 66.41% |
April 09, 2024 | 76.36% |
April 08, 2024 | 84.73% |
April 05, 2024 | 74.79% |
April 04, 2024 | 88.14% |
April 03, 2024 | 92.70% |
April 02, 2024 | 86.79% |
April 01, 2024 | 93.62% |
Date | Value |
---|---|
March 28, 2024 | 76.75% |
March 27, 2024 | 81.19% |
March 26, 2024 | 86.75% |
March 25, 2024 | 97.31% |
March 22, 2024 | 105.9% |
March 21, 2024 | 88.57% |
March 20, 2024 | 93.31% |
March 19, 2024 | 119.7% |
March 18, 2024 | 135.7% |
March 15, 2024 | 107.6% |
March 14, 2024 | 119.0% |
March 13, 2024 | 124.9% |
March 12, 2024 | 129.1% |
March 11, 2024 | 126.6% |
March 08, 2024 | 127.1% |
March 07, 2024 | 140.0% |
March 06, 2024 | 141.5% |
March 05, 2024 | 147.4% |
March 04, 2024 | 159.2% |
March 01, 2024 | 162.7% |
February 29, 2024 | 175.0% |
February 28, 2024 | 173.6% |
February 27, 2024 | 185.7% |
February 26, 2024 | 178.6% |
February 23, 2024 | 185.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.25%
Minimum
Feb 23 2022
351.1%
Maximum
Feb 14 2020
16.47%
Average
9.56%
Median
Oct 11 2023
1 Year Total Returns (Daily) Benchmarks
Karyopharm Therapeutics Inc | -69.13% |
Ardelyx Inc | 86.32% |
Minerva Neurosciences Inc | -48.70% |
Arcutis Biotherapeutics Inc | -46.67% |
4D Molecular Therapeutics Inc | 38.70% |